LMAT
Price
$95.13
Change
-$0.55 (-0.57%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
2.16B
63 days until earnings call
SYK
Price
$389.74
Change
-$3.41 (-0.87%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
148.97B
62 days until earnings call
Interact to see
Advertisement

LMAT vs SYK

Header iconLMAT vs SYK Comparison
Open Charts LMAT vs SYKBanner chart's image
LeMaitre Vascular
Price$95.13
Change-$0.55 (-0.57%)
Volume$4.46K
Capitalization2.16B
Stryker
Price$389.74
Change-$3.41 (-0.87%)
Volume$2.52K
Capitalization148.97B
LMAT vs SYK Comparison Chart in %
Loading...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LMAT vs. SYK commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a StrongBuy and SYK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (LMAT: $95.27 vs. SYK: $389.67)
Brand notoriety: LMAT and SYK are both not notable
LMAT represents the Pharmaceuticals: Other, while SYK is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: LMAT: 81% vs. SYK: 68%
Market capitalization -- LMAT: $2.16B vs. SYK: $148.97B
LMAT [@Pharmaceuticals: Other] is valued at $2.16B. SYK’s [@Medical/Nursing Services] market capitalization is $148.97B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LMAT’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 1 green FA rating(s).

  • LMAT’s FA Score: 1 green, 4 red.
  • SYK’s FA Score: 1 green, 4 red.
According to our system of comparison, LMAT is a better buy in the long-term than SYK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LMAT’s TA Score shows that 3 TA indicator(s) are bullish while SYK’s TA Score has 6 bullish TA indicator(s).

  • LMAT’s TA Score: 3 bullish, 6 bearish.
  • SYK’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SYK is a better buy in the short-term than LMAT.

Price Growth

LMAT (@Pharmaceuticals: Other) experienced а -1.22% price change this week, while SYK (@Medical/Nursing Services) price change was +1.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.89%. For the same industry, the average monthly price growth was +5.50%, and the average quarterly price growth was +9.92%.

Reported Earning Dates

LMAT is expected to report earnings on Oct 30, 2025.

SYK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.91% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($149B) has a higher market cap than LMAT($2.16B). SYK has higher P/E ratio than LMAT: SYK (51.61) vs LMAT (46.47). SYK YTD gains are higher at: 8.709 vs. LMAT (4.565). SYK has higher annual earnings (EBITDA): 5.76B vs. LMAT (73.8M). LMAT has less debt than SYK: LMAT (185M) vs SYK (16.6B). SYK has higher revenues than LMAT: SYK (23.8B) vs LMAT (235M).
LMATSYKLMAT / SYK
Capitalization2.16B149B1%
EBITDA73.8M5.76B1%
Gain YTD4.5658.70952%
P/E Ratio46.4751.6190%
Revenue235M23.8B1%
Total CashN/A2.46B-
Total Debt185M16.6B1%
FUNDAMENTALS RATINGS
LMAT vs SYK: Fundamental Ratings
LMAT
SYK
OUTLOOK RATING
1..100
215
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
1715
SMR RATING
1..100
5656
PRICE GROWTH RATING
1..100
4655
P/E GROWTH RATING
1..100
6722
SEASONALITY SCORE
1..100
4941

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LMAT's Valuation (62) in the Medical Specialties industry is in the same range as SYK (71). This means that LMAT’s stock grew similarly to SYK’s over the last 12 months.

SYK's Profit vs Risk Rating (15) in the Medical Specialties industry is in the same range as LMAT (17). This means that SYK’s stock grew similarly to LMAT’s over the last 12 months.

SYK's SMR Rating (56) in the Medical Specialties industry is in the same range as LMAT (56). This means that SYK’s stock grew similarly to LMAT’s over the last 12 months.

LMAT's Price Growth Rating (46) in the Medical Specialties industry is in the same range as SYK (55). This means that LMAT’s stock grew similarly to SYK’s over the last 12 months.

SYK's P/E Growth Rating (22) in the Medical Specialties industry is somewhat better than the same rating for LMAT (67). This means that SYK’s stock grew somewhat faster than LMAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LMATSYK
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
44%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 9 days ago
56%
Declines
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 17 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PLTY60.970.58
+0.96%
YieldMax PLTR Option Income Strategy ETF
IQLT43.350.10
+0.23%
iShares MSCI Intl Quality Factor ETF
IJAN34.830.06
+0.17%
Innovator Itnl Dvp Pwr Buff ETF™ Jan
PDT13.43-0.01
-0.07%
John Hancock Premium Dividend Fund
NURE29.67-0.07
-0.23%
Nuveen Short-Term REIT ETF

LMAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
+0.42%
ITGR - LMAT
48%
Loosely correlated
-0.36%
SYK - LMAT
46%
Loosely correlated
-0.30%
UFPT - LMAT
44%
Loosely correlated
-1.77%
AORT - LMAT
40%
Loosely correlated
-0.66%
RDNT - LMAT
39%
Loosely correlated
+1.02%
More